- Home
- AUUD vs PTIX Comparison
AUUD vs PTIX Comparison
Compare AUUD & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- PTIX
- Stock Information
- Founded
- AUUD 2012
- PTIX 1994
- Country
- AUUD United States
- PTIX United States
- Employees
- AUUD N/A
- PTIX N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- PTIX Health Care
- Exchange
- AUUD Nasdaq
- PTIX Nasdaq
- Market Cap
- AUUD 2.8M
- PTIX 2.8M
- IPO Year
- AUUD 2021
- PTIX 2016
- Fundamental
- Price
- AUUD $2.65
- PTIX $2.75
- Analyst Decision
- AUUD
- PTIX
- Analyst Count
- AUUD 0
- PTIX 0
- Target Price
- AUUD N/A
- PTIX N/A
- AVG Volume (30 Days)
- AUUD 2.5M
- PTIX 92.4K
- Earning Date
- AUUD 08-19-2025
- PTIX 08-22-2025
- Dividend Yield
- AUUD N/A
- PTIX N/A
- EPS Growth
- AUUD N/A
- PTIX N/A
- EPS
- AUUD N/A
- PTIX N/A
- Revenue
- AUUD N/A
- PTIX N/A
- Revenue This Year
- AUUD N/A
- PTIX N/A
- Revenue Next Year
- AUUD N/A
- PTIX N/A
- P/E Ratio
- AUUD N/A
- PTIX N/A
- Revenue Growth
- AUUD N/A
- PTIX N/A
- 52 Week Low
- AUUD $2.37
- PTIX $2.35
- 52 Week High
- AUUD $31.62
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- AUUD 34.45
- PTIX 38.04
- Support Level
- AUUD $2.37
- PTIX $2.72
- Resistance Level
- AUUD $3.78
- PTIX $2.94
- Average True Range (ATR)
- AUUD 0.60
- PTIX 0.20
- MACD
- AUUD -0.19
- PTIX -0.02
- Stochastic Oscillator
- AUUD 7.16
- PTIX 20.27
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.